Clinical Research in Mexico: Trials and Tribulations
According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be considered to have a healthy investment…
Address: Edificio Scotiabank Inverlat,Piso 12 / Blvd M. Avila Camacho ,1 1009 México D.F.,Mexico
Tel: 52 55 5279 2900
Web: http://www.bakermckenzie.com/Mexico/
Operating in Mexico for nearly 50 years, we have gained a deep understanding of local law and extensive experience assisting domestic and multinational companies. With five offices and a team of more than 240 seasoned professionals that includes lawyers, accountants and economists, we can bring the right talent to any kind of transaction within or outside Mexico. We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
We understand the importance of sharing our knowledge and resources, so we encourage and support our professionals in engaging in pro bono and community service activities. We give legal assistance to various charitable institutions, business and health organizations, carry out fund-raising activities to help nonprofit organizations, and participate in activities aimed at promoting good business practice and improving legal knowledge.
We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be considered to have a healthy investment…
An ambassador for Philips’ global vision of spearheading innovation, business leader of Philips Personal Health Mexico, Eduardo Gutierrez, shares his insights on the key growth drivers in the segment, digitalization,…
Dr. Misael Uribe, chairman and founder at Médica Sur, showcases the reasons for the outstanding performance of the Médica Sur group, which offers high quality and ethical medical practices. Uribe…
Mexico’s medical device segment displays promising growth indicators, with innovative companies providing integrated and digital solutions now firmly embedded within the healthcare landscape. However, regulatory obstacles as well as a…
Hernán Fernández, Managing Partner at Angel Ventures, showcases the crucial role of private investments to enhance the national healthcare system as well as explains his action plan to raise the…
As a firm believer that the family should be at the epicenter of the social fabric of a society, Dr. Felipe Camargo, Medical Director and Founder of Ingenes, shares the…
Marco Cid, Director General of Investigacion Biomedica, shares how he successfully launched an innovative clinical research center (CRC) despite a challenging regulatory environment. He speaks about the inspiration behind his…
Spearheading the key governmental organization in charge of safeguarding the health of the Mexican capital, Minister of Health of Mexico City, José Armando Ahued Ortega, speaks about manoeuvring through the…
Spearheading one of the most trusted and recognizable pharmacy chain brands in the country, Isaac Valdivieso, Director General of Farmacia San Pablo, shares his insights about the company’s stance in…
The CEO of Accelerium Clinical Research, Ciro Garcia speaks about the trends currently impacting Mexico’s clinical research space, while detailing the company’s ambition to pivot from just one full-service research…
Ricardo Spínola, CEO at Farmapiel, explains his clear vision for the company and showcases the added value of Farmapiel’s product offering for both patients and healthcare professionals. Mr. Spínola you…
Positioning itself as a flexible local CRO with an in-depth knowledge of the Mexican market, iLS Clinical Research CEO, Alejandro Arias, shares his insights on how to be the ideal…
See our Cookie Privacy Policy Here
